Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Clinical trial NCT04239443 · UNKNOWN

Trial details

NCT number: NCT04239443
Sponsor: Hunan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer Uterine Cancer Soft Tissue Sarcoma

Start date: 2019-01-30
Primary completion: 2022-03-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.